Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3201
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$4.03B
| $498K | ﹤0.01% |
4,177
+270
| +7% | +$30.4K |
|
|
TWO
3202
DELISTED
Two Harbors Investment
TWO
| $497K | ﹤0.01% |
40,077
-722,977
| -95% | -$8.65M |
|
3203
3D Systems Corp
DDD
$593M
| $496K | ﹤0.01% |
164,337
+5,534
| +3% | +$15.1K |
|
|
FRMI
3204
Fermi Inc
FRMI
$2.89B
| $496K | ﹤0.01% |
54,153
-2,971,284
| -98% | -$18.8M |
|
3205
Everspin Technologies
MRAM
$450M
| $496K | ﹤0.01% |
20,510
-1,331
| -6% | -$29.8K |
|
3206
Fidelity D&D Bancorp
FDBC
$324M
| $495K | ﹤0.01% |
9,635
+210
| +2% | +$9.8K |
|
3207
Franklin Covey
FC
$195M
| $494K | ﹤0.01% |
20,151
+3,422
| +20% | +$78K |
|
3208
Franklin Financial Services
FRAF
$282M
| $494K | ﹤0.01% |
7,890
-307
| -4% | -$17.7K |
|
3209
Hilltop Holdings
HTH
$2.21B
| $493K | ﹤0.01% |
12,721
-19,980
| -61% | -$751K |
|
3210
Neuropace
NPCE
$483M
| $493K | ﹤0.01% |
31,011
-3,834
| -11% | -$61.7K |
|
3211
Deluxe
DLX
$1.12B
| $490K | ﹤0.01% |
20,509
+10,623
| +107% | +$277K |
|
3212
enGene Therapeutics
ENGN
$131M
| $489K | ﹤0.01% |
282,515
+282,173
| +82,507% | +$1.15M |
|
3213
Republic Bancorp
RBCAA
$1.86B
| $488K | ﹤0.01% |
5,394
+1,826
| +51% | +$145K |
|
3214
Agilysys
AGYS
$2.81B
| $487K | ﹤0.01% |
4,662
-142
| -3% | -$11K |
|
|
NFBK
3215
DELISTED
Northfield Bancorp
NFBK
| $485K | ﹤0.01% |
32,958
+3,600
| +12% | +$50.9K |
|
|
PURR
3216
Hyperliquid Strategies Inc
PURR
$2.54B
| $485K | ﹤0.01% |
61,605
+59,935
| +3,589% | +$444K |
|
3217
ATS Corp
ATS
$1.87B
| $484K | ﹤0.01% |
16,814
+13,836
| +465% | +$426K |
|
3218
First Mid Bancshares
FMBH
$1.32B
| $484K | ﹤0.01% |
10,062
-861
| -8% | -$38K |
|
3219
Editas Medicine
EDIT
$396M
| $484K | ﹤0.01% |
149,264
+3,662
| +3% | +$10.7K |
|
3220
BV Financial
BVFL
$177M
| $482K | ﹤0.01% |
22,779
-299
| -1% | -$5.97K |
|
3221
National Healthcare
NHC
$3.56B
| $480K | ﹤0.01% |
2,272
-240
| -10% | -$44.1K |
|
3222
Stoke Therapeutics
STOK
$1.6B
| $478K | ﹤0.01% |
14,606
+4,487
| +44% | +$144K |
|
3223
Vishay Precision Group
VPG
$954M
| $477K | ﹤0.01% |
3,183
-80
| -2% | -$7.43K |
|
3224
OraSure Technologies
OSUR
$271M
| $477K | ﹤0.01% |
106,939
-8,233
| -7% | -$29.1K |
|
3225
Sigma Lithium
SGML
$1.08B
| $476K | ﹤0.01% |
37,635
-243,313
| -87% | -$4.09M |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.